FDA hiring delays persist despite expectations, and Bavarian Nordic names new CEO
The recent discussion about a hiring surge at the U.S. Food and Drug Administration following last year’s DOGE budget cuts has not materialized as expected. Industry observers had anticipated a rapid expansion of staff, but the reality appears more nuanced.
According to the source, bureaucratic hurdles are slowing the hiring process, creating a more complicated picture than the anticipated hiring spree. These delays suggest that administrative and procedural issues are influencing the pace of new appointments.
In separate news, Bavarian Nordic announced the appointment of a new chief executive officer. The leadership change marks a notable development for the company, though further details about the new CEO’s background were not provided.
This writeup was produced by pharmadog from original reporting by STAT. The original article may no longer be reachable at its published URL.
Original headline: “STAT+: Pharmalittle: We’re reading about FDA hiring delays, a new Bavarian Nordic CEO, and more”
read at STAT ↗
comments(0)
5-min edit window · permanent after that